Cheniere Energy Awards 469 Billion EPC Contract to Bechtel for LNG Expansion Lowes Cautions on Shifting Consumer Behavior Signaling Potential Headwinds Target Signals Positive Developments for Shareholders RBI Dividend Payout and Geopolitical Tensions Key Factors Shaping Indian Stock Market This Week Guzman y Gomez Shares Surge Up to 20 on Decision to Exit US Market Focus on Australia Possible FirstDay Valuations for SpaceX OpenAI and Anthropic Could Surpass Berkshire Hathaway According to Polymarket Traders Royal Bank of Canada Q1 2026 Earnings EPS Beats Estimates Amid Resilient Banking Operations BKYI Q1 2026 Earnings EPS Surprise Beats Estimates by 75 PODC Q1 2026 Earnings Narrower Than Expected Loss Signals Improving Cost Discipline OABI Q1 2026 Earnings WiderthanExpected Loss Narrows as EPS Surprises Positively Dana Incorporated DAN Q1 2026 Earnings EPS Misses Consensus Amid Mixed Operating Environment HCXY Q1 2026 Earnings Slight EPS Miss Amid Stable Operations Johnson Controls International JCI Edges Higher on Moderate Volume Holding Above Key Support AleAnna Inc ANNA Slips Nearly 5 as Stock Tests Key Support Zone Tango Therapeutics Drops 638 as Bulls Defend Key Support at 1923 MFS Multimarket Income Trust MMT Holds Steady at 449 as Trading Range Narrows TKO Group Holdings TKO Holds Steady Near Resistance Amid Low Volatility Carvana CVNA Analysts Revise Price Targets Following Stock Split VTS Q1 2026 Earnings EPS Falls Short as Operational Costs Bite BGSF Edges Lower Amid Modest Pullback Key Support Level Holds Celldex Therapeutics CLDX Edges Lower Amid Consolidation Near Key Support TechnipFMC FTI Holds Steady Near 67 as Support and Resistance Levels Come Into Focus Evommune Inc EVMN Slides 146 Amid Cautious Sector Tone Support at 2185 in Focus Eaton Vance TaxManaged BuyWrite Income Fund ETB Edges Higher on Modest Gains Cornerstone Total Return Fund CRF Edges Higher as Income Appeal Drives Modest Gains Apogee Therapeutics APGE Faces Steep Decline Testing Key Support Levels Terns Pharmaceuticals Holds Steady Near Support as Biotech Sentiment Remains Mixed